Concepedia

Ashok Rakhit

AR

Statistics

Publications

45

Citations

2.6K

H-Index

26

Active since

1980

Affiliations

La Roche College(Current)

Novartis (Switzerland)

Roche (Switzerland)

Memorial Sloan Kettering Cancer Center

University of Missouri–Kansas City

Ashok Rakhit is an author at La Roche College specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

1980–2016

45

Publications

45

Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.

Robert J. Motzer, Ashok Rakhit, Lawrence H. Schwartz et al. · PubMed · 1998 · 231 citations

Medicine, Oncology, Pharmacology +13

Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non–small cell lung cancer

Jianfeng Lü, Steve Eppler, J WOLF et al. · Clinical Pharmacology & Therapeutics · 2006 · 224 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS

Jie Ling, Kim A. Johnson, Zhuang Miao et al. · Drug Metabolism and Disposition · 2005 · 222 citations

Medicine, Pharmacokinetics, Pharmacology +14

Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma.

Emilio Bajetta, Michele Del Vecchio, Roberta Mortarini et al. · PubMed · 1998 · 165 citations

Medicine, Oncology, Pharmacology +17

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

Ragy R. Girgis, Mark Slifstein, Deepak Cyril D’Souza et al. · Psychopharmacology · 2016 · 126 citations · Full text

Medicine, Pharmacology, Psychiatry +17

1–5 of 45